Breast Cancer, Lung Cancer (Diagnosis), Prostate Cancer
Conditions
Brief summary
To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.
Interventions
BEHAVIORALreferral for definitive diagnosis based on their cancer screening results
Need for radiological diagnosis
BEHAVIORALEngagement
Engage in stakeholder focus groups to provide feedback about program operations
Sponsors
Florida Department of Health
AdventHealth
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
1. Adult aged 18 or older 2. Seeking care at a CRS or emergency department 3. Meets criteria for lung, breast, and/or prostate cancer screening, as outlined below: 1. Lung cancer: Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years 2. Breast cancer: Women aged 40 to 74 years 3. Prostate cancer: Men aged 55 to 69 years 4. Receives a positive screening result for lung, breast, and/or prostate cancer at a study site
Exclusion criteria
1. Displays behavior disruptive to other patients or staff 2. Refusal to accept screening for breast, lung, and/or prostate cancers
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance, | From enrollment to the end of the 3 month follow-up for a total of 12 months | Reach will assess the percentage and characteristics of patients screened or excluded, as well as participant versus non-participant profiles. Effectiveness will measure the proportion of positive screens referred for confirmatory diagnostics and compare screening rates to Healthy People 2030 goals. Adoption will track provider education on breast, lung, and prostate cancer screening guidelines, uptake of screening practices, and staff engagement with navigation programs. Implementation will evaluate referrals to navigation, screening rates, and for positive screens: referral time, diagnostic barriers, treatment uptake, and clinical trial screening. Maintenance will examine primary outcomes at three months, progress toward HP2030 goals, attrition rates, and differences by patient characteristics. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PROMIS Global Health (HR-QoL) scale | From enrollment to the end of the 3 month follow-up for a total of 12 months | A 10-item scale to assess physical, mental, and social health on a scale of 5 (Excellent) to 1 (Poor), ability to carry out everyday activities on a scale of 5 (Completely) to 1 (Not at all), emotional problems on a scale of 5 (Never) to 1 (Always), fatigue on a scale of 5 (None) to 1 (Very severe), and pain on a scale of 0 (No pain) to 10 (Worst imaginable pain) |
| Patient Satisfaction with Logistical Aspects of Navigation Scale (PSN-L) | From enrollment to the end of the 3 month follow-up for a total of 12 months | A 26-item scale to assess satisfaction with the navigation program on a scale of 3 (Very satisfied) to 1 (Not Satisfied) |
Countries
United States
Contacts
Primary ContactPatricia Robinson, PhD
Outcome results
None listed